Aspirin and tartrazine oral challenge: incidence of adverse response in chronic childhood asthma.
D000293:Adolescent; D001241:Aspirin / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced*; D001391:Azo Compounds / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004485:Eczema / Q000209:etiology; D005541:Forced Expiratory Volume; D006801:Humans; D008450:Maximal Midexpiratory Flow Rate; D011674:Pulse / Q000187:drug effects; D012220:Rhinitis / Q000209:etiology; D013645:Tartrazine / Q000009:adverse effects*
D001391:Azo Compounds; D013645:Tartrazine; D001241:Aspirin